Preprint / Version 1

Murine MHC class II H2-E binds Influenza H19 head distinct from the sialic acid binding site but sterically conflicts with TCR binding

This article is a preprint and has not been certified by peer review.

Authors

    Jianing Zhang,  
    Jianing Zhang
    • National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
    Yeerzhati Tuluhongtayi,  
    Yeerzhati Tuluhongtayi
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • School of Public Health (Shenzhen), Sun Yat-Sen University
    Chengyu Liu,  
    Chengyu Liu
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences
    • University of Chinese Academy of Sciences
    Baihan Huang,  
    Baihan Huang
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    • Faculty of Medicine, University of Macau
    Changliang Wang,  
    Changliang Wang
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    Linjie Li,  
    Linjie Li
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Qiuyang Li,  
    Qiuyang Li
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University
    Jingjing Sheng,  
    Jingjing Sheng
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University
    Xinyu Zhao,  
    Xinyu Zhao
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University
    Chao Lv,  
    Chao Lv
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University
    Chenyang Huang,  
    Chenyang Huang
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    Zeyu Zhang,  
    Zeyu Zhang
    • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University
    Yuhang Gu,  
    Yuhang Gu
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Haichen Wang,  
    Haichen Wang
    • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University
    Yutong Zhai,  
    Yutong Zhai
    • National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
    Hao Qu,  
    Hao Qu
    • University of Chinese Academy of Sciences
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Qiyu Liang,  
    Qiyu Liang
    • National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
    Qile Wu,  
    Qile Wu
    • University of Chinese Academy of Sciences
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Jing Chen,  
    Jing Chen
    • State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University
    • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Medical School, Nanjing University
    Yanfang Zhang,  
    Yanfang Zhang
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Yuxin Chen,  
    Yuxin Chen
    • State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University
    • Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Medical School, Nanjing University
    Yingze Zhao,  
    Yingze Zhao
    • National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
    Hao Song,  
    Hao Song
    • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Key Laboratory of Viral Infectious Diseases, Beijing Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University
    Jincun Zhao,  
    Jincun Zhao
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, National Centre for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
    Xinwen Chen,  
    Xinwen Chen
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, National Centre for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
    George Fu Gao,  
    George Fu Gao
    • National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)
    Jun Liu
    Jun Liu
    • Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory
    • State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, National Centre for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University
Categories
Keywords
MHC class II; Influenza A virus; Host receptor recognition; Protein receptor; T cell receptor

Abstract

Receptor recognition by influenza A virus (IAV) hemagglutinin (HA) is a key determinant of viral entry and host range, traditionally-known to be mediated by sialylated glycans. Previous studies have suggested that major histocompatibility complex class II (MHC II), the antigen-presenting molecule recognized by CD4⁺ T cells, can serve as an entry receptor for several IAVs. The molecular basis of this alternative receptor recognition and its potential implications for MHC II-associated immune functions remain incompletely understood. Here, we report that in vitro expressed H19 bound murine H2-E (I-E), whereas H17 and MHC II from other species tested showed no detectable binding, and a 2.65 Å cryo-electron microscopy structure of the H19/H2-E complex was determined. The H2-E α1 domain binds the lateral surface of the HA head outside the canonical sialic acid-binding pocket, forming three contact regions without directly contacting the peptide presented by H2-E. The key residue candidates within the interaction interface indicate the species-dependent recognition of murine and mallard compared to other species. We also observed two or three H2-E bound to a single H19 trimer, but with limited particle numbers. The structure of two H2-E with one H19 trimer was solved to 6.06 Å and an apo H19 structure was also solved here to 2.67 Å. Structural superposition suggested steric incompatibility of the H19 docking with T cell receptor or HLA-DM binding configurations. These findings define the molecular architecture of H19/MHC II complex recognition and suggest a potential link between influenza receptor usage and MHC II-associated immune functions.

References

1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56(1):152-179. doi:10.1128/mr.56.1.152-179.1992

2. Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol. 2014;385:359-375. doi:10.1007/82_2014_396

3. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300. doi:10.1016/S0140-6736(17)33293-2

4. Zhang W, Shi Y, Lu X, Shu Y, Qi J, Gao GF. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science. 2013;340(6139):1463-1467. doi:10.1126/science.1236787

5. Liu WJ, Wu Y, Bi Y, et al. Emerging HxNy influenza A viruses. Cold Spring Harb Perspect Med. 2022;12(2):a038406. doi:10.1101/cshperspect.a038406

6. Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science. 2005;309(5738):1206. doi:10.1126/science.1115273

7. Wang G, Zhan D, Li L, et al. H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation. J Gen Virol. 2008;89(3):697-702. doi:10.1099/vir.0.83419-0

8. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006;312(5772):404-410. doi:10.1126/science.1124513

9. Stevens J, Blixt O, Glaser L, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol. 2006;355(5):1143-1155. doi:10.1016/j.jmb.2005.11.002

10. Shi Y, Zhang W, Wang F, et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science. 2013;342(6155):243-247. doi:10.1126/science.1242917

11. Wang M, Zhang W, Qi J, et al. Structural basis for preferential avian receptor binding by the human-infecting H10N8 avian influenza virus. Nat Commun. 2015;6:5600. doi:10.1038/ncomms6600

12. Sun X, Shi Y, Lu X, et al. Bat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanism. Cell Rep. 2013;3(3):769-778. doi:10.1016/j.celrep.2013.01.025

13. Olajide OM, Osman MK, Robert J, et al. Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells. PLoS Biol. 2023;21(7):e3002182. doi:10.1371/journal.pbio.3002182

14. Karakus U, Thamamongood T, Ciminski K, et al. MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature. 2019;567(7746):109-112. doi:10.1038/s41586-019-0955-3

15. Karakus U, Mena I, Kottur J, et al. H19 influenza A virus exhibits species-specific MHC class II receptor usage. Cell Host Microbe. 2024;32(7):1089-1102.e10. doi:10.1016/j.chom.2024.05.018

16. Osman MK, Robert J, Broich L, et al. The bat influenza A virus subtype H18N11 induces nanoscale MHCII clustering upon host cell attachment. Nat Commun. 2025;16(1):3847. doi:10.1038/s41467-025-58834-y

17. Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 2014;22(4):183-191. doi:10.1016/j.tim.2014.01.010

18. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993;364(6432):33-39. doi:10.1038/364033a0

19. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203-216. doi:10.1038/nri3818

20. Giotis ES, Carnell G, Young EF, et al. Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nat Microbiol. 2019;4(12):2035-2038. doi:10.1038/s41564-019-0517-3

21. Dadonaite B, Dosey A, Ahn JJ, et al. Defining the molecular interaction between influenza hemagglutinin and MHC-II. bioRxiv. Preprint posted online July 22, 2026. doi:10.64898/2026.07.17.738765

22. Cardenas M, Compton S, Caceres CJ, García-Sastre A, Perez DR, Rajao DS. MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses. Nat Commun. 2026;17(1):2560. doi:10.1038/s41467-026-69267-6

23. Ridgway JBB, Presta LG, Carter P. “Knobs-into-holes” engineering of antibody CH3 domains for heavy-chain heterodimerization. Protein Eng. 1996;9(7):617-621. doi:10.1093/protein/9.7.617

24. Chen J, Zhu X, Huo J, et al. A high-throughput immunopeptidome platform for MHC II alleles to characterize antigen-specific CD4+ T cells. Biomed Technol. 2025;12:100112. doi:10.1016/j.bmt.2025.100112

25. Iwashiro M, Kondo T, Shimizu T, et al. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol. 1993;67(8):4533-4542. doi:10.1128/JVI.67.8.4533-4542.1993

26. Song H, Hao T, Han P, et al. Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin. Cell. 2025;188(4):919-929.e9. doi:10.1016/j.cell.2025.01.019

27. Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14(3):290-296. doi:10.1038/nmeth.4169

28. Punjani A, Zhang H, Fleet DJ. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat Methods. 2020;17(12):1214-1221. doi:10.1038/s41592-020-00990-8

29. He J, Li T, Huang SY. Improvement of cryo-EM maps by simultaneous local and non-local deep learning. Nat Commun. 2023;14(1):3217. doi:10.1038/s41467-023-39031-1

30. Pettersen EF, Goddard TD, Huang CC, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70-82. doi:10.1002/pro.3943

31. Afonine PV, Poon BK, Read RJ, et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D Struct Biol. 2018;74(6):531-544. doi:10.1107/S2059798318006551

32. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(4):486-501. doi:10.1107/S0907444910007493

33. Fereidouni S, Starick E, Karamendin K, et al. Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses. Emerg Microbes Infect. 2023;12(2):2225645. doi:10.1080/22221751.2023.2225645

34. Karakus U, Sempere Borau M, Martínez-Barragán P, et al. MHC class II proteins mediate sialic acid independent entry of human and avian H2N2 influenza A viruses. Nat Microbiol. 2024;9(10):2626-2641. doi:10.1038/s41564-024-01771-1

35. Ciminski K, Reuther P, Rijkers R, de Vries RP, Schwemmle M. The receptor landscape of influenza A viruses. J Virol. 2026;100(8):e01443-25. doi:10.1128/jvi.01443-25

36. de Vries E, Du W, Guo H, de Haan CAM. Influenza A virus hemagglutinin–neuraminidase–receptor balance: preserving virus motility. Trends Microbiol. 2020;28(1):57-67. doi:10.1016/j.tim.2019.08.010

37. Wrobel A, Robert J, Osman M, et al. H18 haemagglutinin binds MHC class II at a site distant from the canonical sialic-acid binding site. Research Square. Preprint posted online September 9, 2026. doi:10.21203/rs.3.rs-10549591/v1

38. Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368(6468):215-221. doi:10.1038/368215a0

39. Ayres CM, Baker BM. Peptide-dependent tuning of major histocompatibility complex motional properties and the consequences for cellular immunity. Curr Opin Immunol. 2022;76:102184. doi:10.1016/j.coi.2022.102184

40. Mullen MM, Haan KM, Longnecker R, Jardetzky TS. Structure of the Epstein–Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell. 2002;9(2):375-385. doi:10.1016/S1097-2765(02)00465-3

41. Smed-Sörensen A, Chalouni C, Chatterjee B, et al. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog. 2012;8(3):e1002572. doi:10.1371/journal.ppat.1002572

42. Ressing ME, van Leeuwen D, Verreck FAW, et al. Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A. 2003;100(20):11583-11588. doi:10.1073/pnas.2034960100

43. Hennecke J, Carfi A, Wiley DC. Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 2000;19(21):5611-5624. doi:10.1093/emboj/19.21.5611

44. Reinherz EL, Tan K, Tang L, et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science. 1999;286(5446):1913-1921. doi:10.1126/science.286.5446.1913

45. Newell EW, Ely LK, Kruse AC, et al. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c–I-Ek. J Immunol. 2011;186(10):5823-5832. doi:10.4049/jimmunol.1100197

46. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM. Two-step binding mechanism for T-cell receptor recognition of peptide–MHC. Nature. 2002;418(6897):552-556. doi:10.1038/nature00920

47. Pos W, Sethi DK, Call MJ, et al. Crystal structure of the HLA-DM–HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell. 2012;151(7):1557-1568. doi:10.1016/j.cell.2012.11.025

48. Jardetzky TS, Brown JH, Gorga JC, et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994;368(6473):711-718. doi:10.1038/368711a0

49. Rödström KEJ, Elbing K, Lindkvist-Petersson K. Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide-MHC demonstrates absence of TCR-peptide contacts. J Immunol. 2014;193(4):1998-2004. doi:10.4049/jimmunol.1401268

50. Ciminski K, Ran W, Gorka M, et al. Bat influenza viruses transmit among bats but are poorly adapted to non-bat species. Nat Microbiol. 2019;4(12):2298-2309. doi:10.1038/s41564-019-0556-9

Metrics

Favorites: 1
Views: 26
Downloads: 3

Downloads

Additional Files

Supplemental File(s)

Posted

2026-11-21

How to Cite

Zhang, J., Tuluhongtayi, Y., Liu, C., Huang, B., Wang, C., Li, L., Li, Q., Sheng, J., Zhao, X., Lv, C., Huang, C., Zhang, Z., Gu, Y., Wang, H., Zhai, Y., Qu, H., Liang, Q., Wu, Q., Chen, J., … Liu, J. (2026). Murine MHC class II H2-E binds Influenza H19 head distinct from the sialic acid binding site but sterically conflicts with TCR binding. LangTaoSha Preprint Server. https://doi.org/10.65215/LTSpreprints.2026.11.20.000395

Download Citation

Declaration of Competing Interests

The authors declare no competing interests to disclose.